Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The primary objective is to compare the efficacy of moxifloxacin 400 mg PO OD for five days with the respective efficacy of amoxicillin clavulanic acid 875/125 mg PO BID for seven days in the treatment of subjects with AECB. The primary efficacy endpoint will be clinical failure rates at 8 weeks post-therapy visit in outpatients with AECB. Clinical failure is defined as the requirement for additional (including increased dose or duration of treatment) systemic antibiotics and/or systemic corticosteroids and/or hospitalization with antibiotic and/or systemic corticosteroid administration within 8 weeks post therapy.
Critère d'inclusion
- Exacerbaciones agudas de bronquitis crónicas (acute exacerbation of chronic bronchitis)